Skip to main content
Market intelligence
IMRXHealthcare

Immuneering Corp insider activity

In the last 90 days, 2 corporate insiders purchased $35,993 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$35,993
Corporate buyers
2
Latest transaction
Jun 23, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 23, 2026Benjamin J. ZeskindPRESIDENT AND CEOOpen Market Purchase2,400$4.56$10,948
Jun 15, 2026Brett Matthew HallCHIEF SCIENTIFIC OFFICEROpen Market Purchase6,035$4.15$25,045